Exogenous insulin‐like growth factor 1 attenuates cisplatin‐induced muscle atrophy in mice

Abstract Background A reduction in the skeletal muscle mass worsens the prognosis of patients with various cancers. Our previous studies indicated that cisplatin administration to mice caused muscle atrophy. This is a concern for human patients receiving cisplatin. The insulin‐like growth factor 1 (...

Descripción completa

Detalles Bibliográficos

Autores principales:	Hiroyasu Sakai, Maho Asami, Hiroaki Naito, Satoko Kitora, Yuta Suzuki, Yu Miyauchi, Rei Tachinooka, Satoshi Yoshida, Risako Kon, Nobutomo Ikarashi, Yoshihiko Chiba, Junzo Kamei
Formato:	Artigo
Lenguaje:	Inglês
Publicado:	Wiley 2021-12-01
Colección:	Journal of Cachexia, Sarcopenia and Muscle
Materias:	Insulin‐like growth factor 1 Cisplatin Muscle atrophy Mecasermin
Acceso en línea:	https://doi.org/10.1002/jcsm.12760
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!